Literature DB >> 11789607

Characterization of isotype-specific regions of five classes of canine beta-tubulin and their expression in several tissues and cell culture.

K Arai1, K Maruo, K Y Ara, K Uehara, H Matsuda.   

Abstract

The structure of isotype-specific regions of classes 1, II, III, IVa and IVb of canine beta-tubulin was characterized by 3'-RACE and the expression of these isotypes in canine tissues was examined by ribonuclease protection assay (RPA). Furthermore, a malignant mammary tumor-derived osteosarcoma-like cell line was established and the altered expression of beta-tubulin isotypes in taxol-resistant sublines was analyzed. The deduced amino acid sequences in isotype-specific regions corresponding to classes I, II and IVb were identical to those of humans and mice, but those in classes III and IVa showed slight differences among species. RPA revealed that classes I and IVb were widely distributed, but classes II, III and IVa were restricted to the brain. Because RPA could clearly distinguish the expression of class IVa from that of class IVb, it was thought to be more useful than northern blot for analysis of beta-tubulin isotype expression. In vitro, taxol-resistant sublines displayed a significant increase in class IVa as compared with taxol-sensitive cells, suggesting that altered expression of class IVa was associated with taxol resistance in these cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11789607     DOI: 10.1292/jvms.63.1297

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.

Authors:  Chang Hoon Moon; Seung Ju Lee; Ho Yong Lee; Le Thi Kim Dung; Wha Ja Cho; HeeJeong Cha; Jeong Woo Park; Young Joo Min
Journal:  Invest New Drugs       Date:  2013-11-08       Impact factor: 3.850

2.  AP-1-mediated expression of brain-specific class IVa β-tubulin in P19 embryonal carcinoma cells.

Authors:  Yuka Maruyama; Kazuhiko Arahara; Emi Kinoshita; Katsuhiko Arai
Journal:  J Vet Med Sci       Date:  2014-09-26       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.